Found: 11
Select item for more details and to access through your institution.
Development of a Biosimilar of Agalsidase Beta for the Treatment of Fabry Disease: Preclinical Evaluation.
- Published in:
- Drugs in R&D, 2023, v. 23, n. 2, p. 141, doi. 10.1007/s40268-023-00421-x
- By:
- Publication type:
- Article
DNA damage and transcription stress cause ATP-mediated redesign of metabolism and potentiation of anti-oxidant buffering.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-12640-5
- By:
- Publication type:
- Article
Multi-OMIC profiling of survival and metabolic signaling networks in cells subjected to photodynamic therapy.
- Published in:
- Cellular & Molecular Life Sciences, 2017, v. 74, n. 6, p. 1133, doi. 10.1007/s00018-016-2401-0
- By:
- Publication type:
- Article
Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity.
- Published in:
- International Journal of Cancer, 2003, v. 103, n. 3, p. 387, doi. 10.1002/ijc.10858
- By:
- Publication type:
- Article
Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-β-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.
- Published in:
- International Journal of Cancer, 2002, v. 98, n. 4, p. 616, doi. 10.1002/ijc.10211
- By:
- Publication type:
- Article
Quantitative analysis of the experimental cytotoxic drug cyclopentenyl cytosine and its metabolite in plasma with HPLC tandem mass spectrometry.
- Published in:
- Biomedical Chromatography, 2008, v. 22, n. 12, p. 1368, doi. 10.1002/bmc.1067
- By:
- Publication type:
- Article
Repeat expansions nested within tandem CNVs: a unique structural change in GLS exemplifies the diagnostic challenges of non-coding pathogenic variation.
- Published in:
- Human Molecular Genetics, 2023, v. 32, n. 1, p. 46, doi. 10.1093/hmg/ddac173
- By:
- Publication type:
- Article
Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma.
- Published in:
- Cellular & Molecular Life Sciences, 2010, v. 67, n. 5, p. 807, doi. 10.1007/s00018-009-0212-2
- By:
- Publication type:
- Article
Absence of cardiotoxicity of the experimental cytotoxic drug cyclopentenyl cytosine (CPEC) in rats.
- Published in:
- Archives of Toxicology, 2005, v. 79, n. 5, p. 268, doi. 10.1007/s00204-004-0633-5
- By:
- Publication type:
- Article
In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia.
- Published in:
- British Journal of Haematology, 2000, v. 110, n. 1, p. 161, doi. 10.1046/j.1365-2141.2000.02136.x
- By:
- Publication type:
- Article
Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells
- Published in:
- FEBS Letters, 2002, v. 527, n. 1-3, p. 229, doi. 10.1016/S0014-5793(02)03234-9
- By:
- Publication type:
- Article